Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells
Condition: Diabetes Mellitus, Type 1 Interventions: Biological: Mesenchymal Stem Cells (MSCs); Other: Placebo Infusion (Plasmalyte A with 0.5% human serum albumin) Sponsors: Medical University of South Carolina; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diabetes | Diabetes Type 1 | Endocrinology | Research | Stem Cell Therapy | Stem Cells | Urology & Nephrology